Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-09 4:45 pm Purchase |
2024-11-27 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 4,530,374 42.000% |
1,000,000 (+28.33%) |
Filing History |
| 2024-07-05 4:01 pm Purchase |
2024-06-06 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 3,530,374 38.000% |
862,917 (+32.35%) |
Filing History |
| 2024-03-26 4:03 pm Purchase |
2024-03-20 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,667,457 81.400% |
40,224 (+1.53%) |
Filing History |
| 2024-03-07 07:47 am Purchase |
2024-03-05 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,627,233 81.100% |
26,338 (+1.01%) |
Filing History |
| 2024-02-14 4:01 pm Purchase |
2024-02-13 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,600,895 81.000% |
61,564 (+2.42%) |
Filing History |
| 2024-02-05 07:19 am Purchase |
2024-02-01 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,539,331 80.600% |
23,320 (+0.93%) |
Filing History |
| 2024-01-17 4:19 pm Purchase |
2024-01-16 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,516,011 80.400% |
44,421 (+1.80%) |
Filing History |
| 2024-01-09 4:16 pm Sale |
2024-01-03 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,471,590 80.200% |
-39,414 (-1.57%) |
Filing History |
| 2023-12-13 5:11 pm Purchase |
2023-12-05 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,511,004 80.400% |
159,399 (+6.78%) |
Filing History |
| 2023-11-16 4:01 pm Purchase |
2023-11-15 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,351,605 79.400% |
20,191 (+0.87%) |
Filing History |
| 2023-11-01 4:28 pm Purchase |
2023-08-22 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,331,414 79.200% |
80,037 (+3.56%) |
Filing History |
| 2023-08-24 4:48 pm Sale |
2023-07-21 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,251,377 78.600% |
-14,730 (-0.65%) |
Filing History |
| 2023-04-12 4:05 pm Purchase |
2023-04-04 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,266,107 78.800% |
7,785 (+0.34%) |
Filing History |
| 2023-03-22 4:16 pm Purchase |
2023-03-15 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 2,258,321 78.700% |
363,179 (+19.16%) |
Filing History |
| 2023-02-17 07:01 am Purchase |
2023-02-15 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,895,142 75.600% |
272,128 (+16.77%) |
Filing History |
| 2023-01-27 4:01 pm Sale |
2023-01-25 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,623,014 72.600% |
-202,333 (-11.08%) |
Filing History |
| 2022-12-15 4:06 pm Purchase |
2022-12-14 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,825,347 74.900% |
135,299 (+8.01%) |
Filing History |
| 2022-10-25 4:05 pm Purchase |
2022-10-21 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,690,048 73.400% |
110,763 (+7.01%) |
Filing History |
| 2022-08-23 4:11 pm Sale |
2022-08-16 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,579,285 72.100% |
-29,339 (-1.82%) |
Filing History |
| 2022-06-24 4:17 pm Purchase |
2022-06-06 | 13D | AgeX Therapeutics, Inc. AGE |
Juvenescence Ltd | 1,608,624 72.500% |
304,289 (+23.33%) |
Filing History |